Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Withdrawn Phase 2 Interventional

S0408: Capecitabine, Oxaliplatin, and Bevacizumab in Pts Undergoing Surgery for Liver Mets From Colorectal Cancer

ClinicalTrials.gov ID: NCT00118105

Public ClinicalTrials.gov record NCT00118105. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 3:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Trial of Neoadjuvant Capecitabine, Oxaliplatin, and Bevacizumab for Resectable Colorectal Metastases in the Liver

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Drugs used in chemotherapy, such as capecitabine and oxaliplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. Bevacizumab may also stop the growth of tumor cells by blocking blood flow to the tumor. Giving capecitabine and oxaliplatin together with bevacizumab before and after surgery may be an effective treatment for liver metastases. PURPOSE: This phase II trial is studying how well giving capecitabine and oxaliplatin together with bevacizumab works in treating patients who are undergoing surgery for liver metastases due to colorectal cancer.

Study identification

NCT ID
NCT00118105
Recruitment status
Withdrawn
Study type
Interventional
Phase
Phase 2
Lead sponsor
SWOG Cancer Research Network
Network
Enrollment
Not listed

Conditions and interventions

Interventions

Biological · Drug · Procedure

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2006 (Type not available)
Primary completion
Apr 2007 (Actual)
Completion
Apr 2007 (Actual)
Last update posted
Jan 3, 2013

2006 – 2007

United States locations

U.S. sites
46
U.S. states
11
U.S. cities
28
Facility City State ZIP Site status
USC/Norris Comprehensive Cancer Center and Hospital Los Angeles California 90089-9181 —
Rush-Copley Cancer Care Center Aurora Illinois 60507 —
Joliet Oncology-Hematology Associates, Limited - West Joliet Illinois 60435 —
Carle Cancer Center at Carle Foundation Hospital Urbana Illinois 61801 —
CCOP - Carle Cancer Center Urbana Illinois 61801 —
St. Francis Hospital and Health Centers - Beech Grove Campus Beech Grove Indiana 46107 —
Saint Anthony Memorial Health Centers Michigan City Indiana 46360 —
Reid Hospital & Health Care Services, Incorporated Richmond Indiana 47374 —
Tammy Walker Cancer Center at Salina Regional Health Center Salina Kansas 67401 —
Cancer Research Center at Boston Medical Center Boston Massachusetts 02118 —
West Michigan Cancer Center Kalamazoo Michigan 49007-3731 —
Bronson Methodist Hospital Kalamazoo Michigan 49007 —
Borgess Medical Center Kalamazooaa Michigan 49001 —
CCOP - Montana Cancer Consortium Billings Montana 59101 —
Hematology-Oncology Centers of the Northern Rockies - Billings Billings Montana 59101 —
Northern Rockies Radiation Oncology Center Billings Montana 59101 —
St. Vincent Healthcare Billings Montana 59101 —
Billings Clinic Cancer Center Billings Montana 59107-5100 —
Deaconess Billings Clinic - Downtown Billings Montana 59107-7000 —
Bozeman Deaconess Cancer Center Bozeman Montana 59715 —
St. James Community Hospital Butte Montana 59701 —
Frontier Cancer Center Great Falls Montana 59405 —
Great Falls Clinic Great Falls Montana 59405 —
St. Peter's Hospital Helena Montana 59601 —
Glacier Oncology, PLLC Kalispell Montana 59901 —
Kalispell Medical Oncology Kalispell Montana 59901 —
Kalispell Regional Medical Center Kalispell Montana 59901 —
Community Medical Center Missoula Montana 59801 —
Guardian Oncology and Center for Wellness Missoula Montana 59804 —
Montana Cancer Specialists at Montana Cancer Center Missoula Montana 59807-7877 —
Montana Cancer Center at St. Patrick Hospital and Health Sciences Center Missoula Montana 59807 —
Wayne Memorial Hospital, Incorporated Goldsboro North Carolina 27534 —
Grandview Hospital Dayton Ohio 45405 —
Good Samaritan Hospital Dayton Ohio 45406 —
David L. Rike Cancer Center at Miami Valley Hospital Dayton Ohio 45409 —
Samaritan North Cancer Care Center Dayton Ohio 45415 —
Veterans Affairs Medical Center - Dayton Dayton Ohio 45428 —
CCOP - Dayton Dayton Ohio 45429 —
Blanchard Valley Medical Associates Findlay Ohio 45840 —
Charles F. Kettering Memorial Hospital Kettering Ohio 45429 —
St. Rita's Medical Center Lima Ohio 45801 —
Middletown Regional Hospital Middletown Ohio 45044 —
UVMC Cancer Care Center at Upper Valley Medical Center Troy Ohio 45373-1300 —
Ruth G. McMillan Cancer Center at Greene Memorial Hospital Xenia Ohio 45385 —
Danville Regional Medical Center Danville Virginia 24541 —
Welch Cancer Center at Sheridan Memorial Hospital Sheridan Wyoming 82801 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00118105, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 3, 2013 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00118105 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →